SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-013228
Filing Date
2021-03-04
Accepted
2021-03-03 17:55:53
Documents
53
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_gxacquisitioncorp.htm 10-K 842498
2 CERTIFICATION f10k2020ex31-1_gxacquisition.htm EX-31.1 11911
3 CERTIFICATION f10k2020ex31-2_gxacquisition.htm EX-31.2 11897
4 CERTIFICATION f10k2020ex31-3_gxacquisition.htm EX-31.3 11933
5 CERTIFICATION f10k2020ex32-1_gxacquisition.htm EX-32.1 4638
6 CERTIFICATION f10k2020ex32-2_gxacquisition.htm EX-32.2 4663
7 CERTIFICATION f10k2020ex32-3_gxacquisition.htm EX-32.3 4643
  Complete submission text file 0001213900-21-013228.txt   2931076

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE gxgx-20201231.xml EX-101.INS 247315
9 XBRL SCHEMA FILE gxgx-20201231.xsd EX-101.SCH 36665
10 XBRL CALCULATION FILE gxgx-20201231_cal.xml EX-101.CAL 21524
11 XBRL DEFINITION FILE gxgx-20201231_def.xml EX-101.DEF 180080
12 XBRL LABEL FILE gxgx-20201231_lab.xml EX-101.LAB 307972
13 XBRL PRESENTATION FILE gxgx-20201231_pre.xml EX-101.PRE 181032
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
GX Acquisition Corp. (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38914 | Film No.: 21710955
SIC: 2834 Pharmaceutical Preparations